Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …

Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …

Background Identifying new antifungals for cryptococcal meningitis is a priority given the
inadequacy of current therapy. Sertraline has previously shown in vitro and in vivo activity …

Objective: To assess technical and operational performance of a dried blood spot (DBS)-based
HIV-1 RNA service for remote healthcare facilities in a low-income country. Design: A …

Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel
pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due …

Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …

Background Cryptococcal meningitis is a common cause of AIDS-related mortality. Although
symptom recurrence after initial treatment is common, the etiology is often difficult to …

Depression interventions for individuals with HIV/AIDS in Africa are being increasingly
evaluated. MEDLINE was searched using key terms: depression, Africa, and HIV, to identify …